| 摘要 |
PROBLEM TO BE SOLVED: To provide an inhibitor to enterokinesis aggravative action caused by nonsteroidal anti-inflammatory drugs, and to provide an antiinflammatory composition decreased in enterokinesis aggravating action. SOLUTION: The inhibitor to enterokinesis aggravating action caused by a nonsteroidal antiinflammatory drug selected from diclofenac sodium and loxoprofen sodium includes tiquizium bromide or scopolamine butylbromide as an active ingredient. COPYRIGHT: (C)2010,JPO&INPIT
|
